{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:27:20Z","timestamp":1794666440654,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanxi Provincial Social Development Project","award":["201903D321033"],"award-info":[{"award-number":["201903D321033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94754-z","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T02:11:18Z","timestamp":1742609478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nomogram for the prediction of valproic acid induced platelet decline: a nested case\u2013control study"],"prefix":"10.1038","volume":"15","author":[{"given":"Gang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8756-1190","authenticated-orcid":false,"given":"Jinlin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"issue":"5","key":"94754_CR1","first-page":"1382","volume":"27","author":"A Sarwal","year":"2021","unstructured":"Sarwal, A. Neurologic complications in the postoperative neurosurgery patient. Continuum (Minneap Minn). 27(5), 1382\u20131404 (2021).","journal-title":"Continuum (Minneap Minn)."},{"issue":"4","key":"94754_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3171\/2012.12.JNS111970","volume":"118","author":"AS Wu","year":"2013","unstructured":"Wu, A. S. et al. A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J. Neurosurg. 118(4), 873\u2013883 (2013).","journal-title":"J. Neurosurg."},{"issue":"4","key":"94754_CR3","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s10072-021-05697-y","volume":"43","author":"M Anbarlouei","year":"2022","unstructured":"Anbarlouei, M., Emamikhah, M., Basiri, K. & Farzanegan, G. Perioperative routine EEG can reliably predict de novo seizures after supratentorial craniotomy. Neurol. Sci. 43(4), 2717\u20132722 (2022).","journal-title":"Neurol. Sci."},{"issue":"1","key":"94754_CR4","first-page":"63","volume":"125","author":"N Morris","year":"1981","unstructured":"Morris, N., Barr, R. D., Pai, K. R. & Kelton, J. G. Valproic acid and thrombocytopenia. Can. Med. Assoc. J. 125(1), 63\u201364 (1981).","journal-title":"Can. Med. Assoc. J."},{"issue":"1","key":"94754_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-017-0224-6","volume":"18","author":"M Buoli","year":"2018","unstructured":"Buoli, M., Serati, M., Botturi, A. & Altamura, A. C. The risk of thrombocytopenia during valproic acid therapy: A critical summary of available clinical data. Drugs R&D 18(1), 1\u20135 (2018).","journal-title":"Drugs R&D"},{"key":"94754_CR6","unstructured":"Tang, J. L., Lin, Q., Yan, J., Suying. Analysis of the factors related the severity of valproic acid-related hematologic adverse drug reactions. Pract. Pharm. Clin. Remedies 23(5), 466\u2013470 (2020)."},{"issue":"5","key":"94754_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/jcpt.13125","volume":"45","author":"DW Kim","year":"2020","unstructured":"Kim, D. W., Kim, W., Lee, C. H. & Chun, Y. I. Thrombocytopenia during intravenous valproic acid therapy in the neurological intensive care unit. J. Clin. Pharm. Ther. 45(5), 1014\u20131020 (2020).","journal-title":"J. Clin. Pharm. Ther."},{"issue":"12","key":"94754_CR8","first-page":"CD011412","volume":"12","author":"SJ Nevitt","year":"2017","unstructured":"Nevitt, S. J., Sudell, M., Weston, J., Tudur Smith, C. & Marson, A. G. Antiepileptic drug monotherapy for epilepsy: A network meta-analysis of individual participant data. Cochrane Database Syst. Rev. 12(12), CD011412 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"94754_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","volume":"44","author":"E Trinka","year":"2017","unstructured":"Trinka, E. & Kalviainen, R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure 44, 65\u201373 (2017).","journal-title":"Seizure"},{"key":"94754_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yebeh.2018.01.039","volume":"82","author":"SD Shorvon","year":"2018","unstructured":"Shorvon, S. D., Bermejo, P. E., Gibbs, A. A., Huberfeld, G. & Kalviainen, R. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection. Epilepsy Behav. 82, 91\u2013103 (2018).","journal-title":"Epilepsy Behav."},{"issue":"10","key":"94754_CR11","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/jnnp-2014-308584","volume":"86","author":"T Iuchi","year":"2015","unstructured":"Iuchi, T. et al. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: A phase II prospective, randomised study. J. Neurol. Neurosurg. Psychiatry 86(10), 1158\u20131162 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"94754_CR12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1080\/02699052.2023.2184495","volume":"37","author":"A Hedges","year":"2023","unstructured":"Hedges, A. et al. Levetiracetam dosing for seizure prophylaxis in neurocritical care patients. Brain Inj. 37(10), 1167\u20131172 (2023).","journal-title":"Brain Inj."},{"issue":"1","key":"94754_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1684\/epd.2017.0889","volume":"19","author":"J Kim","year":"2017","unstructured":"Kim, J. & Shin, J. W. Levetiracetam-induced thrombocytopenia in a patient with status epilepticus. Epileptic Disord. 19(1), 104\u2013108 (2017).","journal-title":"Epileptic Disord."},{"issue":"3","key":"94754_CR14","first-page":"e13817","volume":"13","author":"ST Nwaedozie","year":"2021","unstructured":"Nwaedozie, S. T., Aatrai, S., Najjar Mojarrab, J. & Al, T. A. Acute levetiracetam-induced thrombocytopenia in an anticoagulated immunocompetent patient. Cureus 13(3), e13817 (2021).","journal-title":"Cureus"},{"issue":"3","key":"94754_CR15","first-page":"002449","volume":"8","author":"M Ammad Ud Din","year":"2021","unstructured":"Ammad Ud Din, M., Ather Hussain, S. & Bodrog, A. Delayed Recognition of Levetiracetam-induced Pancytopenia. Eur. J. Case Rep. Intern. Med. 8(3), 002449 (2021).","journal-title":"Eur. J. Case Rep. Intern. Med."},{"issue":"1","key":"94754_CR16","doi-asserted-by":"publisher","first-page":"26064","DOI":"10.1038\/s41598-024-77768-x","volume":"14","author":"H Zhao","year":"2024","unstructured":"Zhao, H. et al. A nomogram incorporating linezolid and metabolite concentrations for predicting linezolid induced thrombocytopenia in patients with renal impairment. Sci. Rep. 14(1), 26064 (2024).","journal-title":"Sci. Rep."},{"issue":"2","key":"94754_CR17","doi-asserted-by":"publisher","first-page":"e0264351","DOI":"10.1371\/journal.pone.0264351","volume":"17","author":"DS Post","year":"2022","unstructured":"Post, D. S. et al. Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study. PLoS One 17(2), e0264351 (2022).","journal-title":"PLoS One"},{"issue":"6","key":"94754_CR18","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00003246-200006000-00031","volume":"28","author":"S Vanderschueren","year":"2000","unstructured":"Vanderschueren, S. et al. Thrombocytopenia and prognosis in intensive care. Crit. Care Med. 28(6), 1871\u20131876 (2000).","journal-title":"Crit. Care Med."},{"issue":"4","key":"94754_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0887-8994(96)00052-5","volume":"14","author":"IN Allarakhia","year":"1996","unstructured":"Allarakhia, I. N., Garofalo, E. A., Komarynski, M. A. & Robertson, P. L. Valproic acid and thrombocytopenia in children: A case-controlled retrospective study. Pediatr. Neurol. 14(4), 303\u2013307 (1996).","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"94754_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","volume":"49","author":"W Nasreddine","year":"2008","unstructured":"Nasreddine, W. & Beydoun, A. Valproate-induced thrombocytopenia: A prospective monotherapy study. Epilepsia 49(3), 438\u2013445 (2008).","journal-title":"Epilepsia"},{"issue":"4","key":"94754_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.410050414","volume":"5","author":"AN Neophytides","year":"1979","unstructured":"Neophytides, A. N., Nutt, J. G. & Lodish, J. R. Thrombocytopenia associated with sodium valproate treatment. Ann. Neurol. 5(4), 389\u2013390 (1979).","journal-title":"Ann. Neurol."},{"issue":"17","key":"94754_CR22","first-page":"1397","volume":"30","author":"H von Voss","year":"1978","unstructured":"von Voss, H., Schulte-Berbuhl, R. & Gobel, U. Side effects of sodium valproate (sodium di-N-propylacetate) on malonyldialdehyde-production and other platelet function tests. Minerva Pediatr. 30(17), 1397\u20131404 (1978).","journal-title":"Minerva Pediatr."},{"issue":"7","key":"94754_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s10072-014-1701-0","volume":"35","author":"A Verrotti","year":"2014","unstructured":"Verrotti, A., Scaparrotta, A., Grosso, S., Chiarelli, F. & Coppola, G. Anticonvulsant drugs and hematological disease. Neurol. Sci. 35(7), 983\u2013993 (2014).","journal-title":"Neurol. Sci."},{"key":"94754_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/DHPS.S458284","volume":"16","author":"Z Al Qamariat","year":"2024","unstructured":"Al Qamariat, Z. et al. Rapid onset and recovery linezolid-induced thrombocytopenia: A large-sample, single-center retrospective cohort study. Drug Healthc. Patient Saf. 16, 43\u201349 (2024).","journal-title":"Drug Healthc. Patient Saf."},{"issue":"8","key":"94754_CR25","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/jcm13082380","volume":"13","author":"AK Thabit","year":"2024","unstructured":"Thabit, A. K. et al. Linezolid-associated thrombocytopenia: Assessment of risk factors in patients without hemato-oncologic diseases. J. Clin. Med. 13(8), 2380 (2024).","journal-title":"J. Clin. Med."},{"issue":"3","key":"94754_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/jcm12030933","volume":"12","author":"I Olaizola","year":"2023","unstructured":"Olaizola, I., Brodde, M. F., Kehrel, B. E. & Evers, S. The impact of levetiracetam and valproate on platelet functions-A double-blind, placebo-controlled crossover study. J. Clin. Med. 12(3), 933 (2023).","journal-title":"J. Clin. Med."},{"issue":"1","key":"94754_CR27","first-page":"144","volume":"22","author":"MQG Hongyan","year":"2019","unstructured":"Hongyan, M. Q. G. Literature analysis on 322 cases of fibrinogen reduction induced by valproate. China Pharm. 22(1), 144\u2013147 (2019).","journal-title":"China Pharm."},{"issue":"2","key":"94754_CR28","first-page":"305","volume":"38","author":"DK Dong Yan","year":"2017","unstructured":"Dong Yan, D. K. & Aixiang, H. Effect of valproate sodium on fibrinogen in children with epilepsy. Guangdong Med. J. 38(2), 305\u20137 (2017).","journal-title":"Guangdong Med. J."},{"issue":"2","key":"94754_CR29","first-page":"66","volume":"10","author":"LL-I Zeng Yan","year":"2013","unstructured":"Zeng Yan, L.L.-I. & Yan, S. Analysis of liver function and blood routine of the patients with sodium valproate serum concentration above. Chin. J. Drug Appl. Monit. 10(2), 66\u201370 (2013).","journal-title":"Chin. J. Drug Appl. Monit."},{"key":"94754_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.seizure.2021.11.018","volume":"94","author":"W Nasreddine","year":"2022","unstructured":"Nasreddine, W. et al. Predicting the occurrence of thrombocytopenia from free valproate levels: A prospective study. Seizure 94, 33\u201338 (2022).","journal-title":"Seizure"},{"issue":"8","key":"94754_CR31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1177\/10600280211055508","volume":"56","author":"J Guo","year":"2022","unstructured":"Guo, J. et al. Valproic acid after neurosurgery induces elevated risk of liver injury: A prospective nested case-control study. Ann. Pharmacother. 56(8), 888\u2013897 (2022).","journal-title":"Ann. Pharmacother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94754-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94754-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94754-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T02:12:03Z","timestamp":1742609523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94754-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94754"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94754-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Study approval was granted by the Ethics Committee of the Shanxi Provincial People\u2019s Hospital (No. 2019\u201336). Additionally, this study conformed to the moral standards formulated in the 1964 Declaration of Helsinki and its subsequent amendments or similar ethical guidelines. Written informed consent was waived by the Ethics Committee of Shanxi Provincial People\u2019s Hospital due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"9874"}}